SEC Form 4 · accession 0001209191-16-104917
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Barry
Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 29, 2016 | A | 1,000 | $0.00 | A | 3,166,014 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $13.71 | Feb 29, 2016 | A | 10,500 | A | — | Feb 28, 2026 | Common Stock | 10,500 | 10,500 | D |
Explanation of responses
- F1This Restricted Stock Award will vest in full on the first year anniversary of the Issuer's 2016 annual meeting of stockholders.
- F2This option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Issuer's 2016 annual meeting of stockholders.